Device type · LZG
Pump, Infusion, Insulin
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LZG
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
16
510(k), De Novo and PMA
Adverse event reports
10,593
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Pump, Infusion, Insulin
- Product code
- LZG
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 880.5725
- FDA record
- Classification database entry for LZG
Latest FDA decisions
The 8 newest of 16 since 2015.
K262153 · Decided Sep 2, 2026 · 68 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
K253534 · Decided Apr 8, 2026 · 146 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
K240158 · Decided Sep 4, 2024 · 229 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
13 more FDA decisions with a free account
Reports received
10,593
Received Nov 1, 2025 to Nov 19, 2026. Includes 29 of another or unstated type.
Malfunction reports
9,957
94% of reports
Injury reports
600
5.7% of reports
Death reports
7
0.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1,375 | 111 | 0 | 0 |
| Jan 24 | 1,489 | 133 | 0 | 1 |
| Feb 24 | 1,356 | 111 | 0 | 0 |
| Mar 24 | 1,426 | 105 | 1 | 0 |
| Apr 24 | 1,397 | 92 | 0 | 0 |
| May 24 | 1,531 | 121 | 0 | 0 |
| Jun 24 | 1,144 | 99 | 0 | 0 |
| Jul 24 | 1,914 | 133 | 1 | 0 |
| Aug 24 | 1,520 | 93 | 0 | 0 |
| Sep 24 | 1,561 | 82 | 0 | 0 |
| Oct 24 | 1,440 | 114 | 0 | 0 |
| Nov 24 | 1,068 | 81 | 1 | 0 |
| Dec 24 | 1,128 | 86 | 0 | 0 |
| Jan 25 | 1,150 | 111 | 2 | 0 |
| Feb 25 | 789 | 61 | 0 | 0 |
| Mar 25 | 1,143 | 63 | 2 | 0 |
| Apr 25 | 861 | 72 | 0 | 0 |
| May 25 | 845 | 49 | 1 | 0 |
| Jun 25 | 929 | 41 | 0 | 0 |
| Jul 25 | 976 | 59 | 0 | 0 |
| Aug 25 | 717 | 51 | 0 | 0 |
| Sep 25 | 1,105 | 72 | 0 | 0 |
| Oct 25 | 1,241 | 59 | 0 | 0 |
| Nov 25 | 801 | 42 | 1 | 0 |
| Dec 25 | 867 | 41 | 0 | 0 |
| Jan 26 | 828 | 25 | 0 | 0 |
| Feb 26 | 683 | 34 | 1 | 0 |
| Mar 26 | 826 | 50 | 0 | 0 |
| Apr 26 | 790 | 38 | 1 | 0 |
| May 26 | 711 | 37 | 1 | 0 |
| Jun 26 | 990 | 85 | 0 | 0 |
| Jul 26 | 988 | 101 | 2 | 9 |
| Aug 26 | 829 | 52 | 0 | 7 |
| Sep 26 | 948 | 63 | 0 | 3 |
| Oct 26 | 696 | 32 | 1 | 10 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
4 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Unintended Movement2,050
- Loss of or Failure to Bond1,837
- Obstruction of Flow1,601
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions5,979
- Hyperglycemia4,360
- Hemorrhage/Blood Loss/Bleeding262
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2604-2026 · Started May 20, 2026 · Posted by FDA Jun 30, 2026
Reason given: External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may...
Cause as FDA categorized it: Process design
Z-2605-2026 · Started May 20, 2026 · Posted by FDA Jun 30, 2026
Reason given: External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may...
Cause as FDA categorized it: Process design
- Paradigm Insulin Pump (MMT-712, MMT-715)Open, Classified
Z-1748-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
123 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.